Susquehanna International Group, LLP Aquestive Therapeutics, Inc. Put Options Transaction History

Susquehanna International Group, LLP

  • $560 Billion
  • Q3 2024

Put Options

5 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$2.4 - $5.09 $24,720 - $52,427
-10,300 Reduced 6.54%
147,200 $733,000
Q2 2024

Aug 15, 2024
SELL
$2.31 - $4.5 $381,843 - $743,850
-165,300 Reduced 51.21%
157,500 $409,000
Q1 2024

May 07, 2024
BUY
$2.01 - $6.09 $564,407 - $1.71 Million
280,800 Added 668.57%
322,800 $1.38 Million
Q4 2023

Feb 14, 2024
BUY
$1.29 - $2.47 $38,184 - $73,112
29,600 Added 238.71%
42,000 $84,000
Q3 2023

Nov 14, 2023
BUY
$1.5 - $2.24 $18,600 - $27,776
12,400 New
12,400 $18,000

Others Institutions Holding AQST

# of Institutions
122
Shares Held
46.8M
Call Options Held
517K
Put Options Held
207K
View Full List

About Aquestive Therapeutics, Inc.

AQST Quotes by TradingView
  • Ticker AQST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 53,350,700
  • Market Cap $188M
  • Description
  • Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual f...
More about AQST
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email